Atea Pharmaceuticals, Inc. (AVIR) stock
AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.99+0.03 (+0.76%)
Close on Nov 18, 2026Market cap $320.02MP/E –Yield –
Atea Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Atea Pharmaceuticals's market cap was $338.46M on Nov 11, 2026, against $242.19M a year earlier. Over the last 5 years it ranged from $235.30M to $742.44M, with a median of $325.02M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $338.46M | +21.4% |
| 2025 | Dec 31, 2025 | $278.91M | -1.4% |
| 2024 | Dec 31, 2024 | $282.95M | +11.2% |
| 2023 | Dec 29, 2023 | $254.48M | -36.5% |
| 2022 | Dec 30, 2022 | $400.61M | -46.0% |
| 2021 | Dec 31, 2021 | $742.44M | +75.8% |
| 2020 | Dec 31, 2020 | $422.39M | – |
See a number that looks wrong?